Sarah A. O'Dowd
Known title: DirectorCIK: 0001447149
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Ichor Holdings to Report Q3 2026 Earnings on Nov 2. Ichor Holdings has scheduled its third-quarter 2026 financial results announcement for November 2nd. This upcoming report will provide investors with the latest financial data for the company. The stock is currently trading near a key support level, which may influence how the market reacts to the earnings release.
Transaction History
| PTGX | ▲ Buy | Grant | 2,695 | $0 | 1/2/2026 | View on chart |
| PTGX | ▲ Buy | Grant | 5,130 | $0 | 1/2/2025 | View on chart |
| ICHR | ▲ Buy | Grant | 3,923 | $0 | 5/15/2024 | View on chart |
| ICHR | ▲ Buy | Grant | 4,752 | $0 | 5/18/2023 | View on chart |
| ICHR | ▲ Buy | Grant | 5,635 | $0 | 5/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
PTGX featured in recent SeekingAlpha and Benzinga articles
A SeekingAlpha column noted Johnson & Johnson’s strong catalysts while keeping a hold stance, a view that may influence sentiment toward biotech peers such as Protagonist Therapeutics. Separately, Benzinga published a piece examining how a $100 investment in PTGX ten years ago would have grown, highlighting the stock’s historical performance. These mentions reflect ongoing analyst and investor interest in the company.
PTGX featured in recent SeekingAlpha and Benzinga articles. A SeekingAlpha column noted Johnson & Johnson’s strong catalysts while keeping a hold stance, a view that may influence sentiment toward biotech peers such as Protagonist Therapeutics. Separately, Benzinga published a piece examining how a $100 investment in PTGX ten years ago would have grown, highlighting the stock’s historical performance. These mentions reflect ongoing analyst and investor interest in the company.